Restorative Effect of Distillated Nerium Oleander Extract on Diabetic Neuropathy: Animal Model Study by Yanardag, Sirma Basak et al.
16 Journal of Advanced Neuroscience Research, 2015, 2, 16-21  
 
 E-ISSN: 2409-3564/15  © 2015 Cosmos Scholars Publishing House 
Restorative Effect of Distillated Nerium Oleander Extract on 
Diabetic Neuropathy: Animal Model Study 
Sirma Basak Yanardag1, Ahmet Akkoca1, Figen Çiçek2 and Murat Ayaz1,* 
1Selçuk University Medical Faculty Department of Biophysics, Alaaddin Keykubat Kampusu 42075, Konya, 
Turkey 
2Çukurova University Faculty of Medicine Department of Biophysics, Adana, Turkey 
Abstract: The current study aims to investigate the possible role of Nerium oleander (NeOL) distillate in the treatment of 
diabetic neuropathy. The restorative affects of distillated NeOL on the diabetes-induced electrophysiological alterations 
were investigated. Induction of diabetes was done by the combination of single dose streptozotocin injection together 
with a high fat diet for four weeks. Experimental groups were designed as follows: control, diabetic, and NeOL treated 
diabetic. Nerve conduction velocity (CV) recordings were performed through a suction electrode from the tibia branch of 
the sciatic nerve trunk. Diabetes results an increase in rheobase, chronaxie values together with a decrease in maximum 
depolarization (MD), compound action potential (CAP) area and CV measurements. With its antioxidant nature, NeOL 
treatment produced nearly complete restorations of the diabetes-induced alterations. Current study has shown that 
distillated NeOL (375 µg /0.5 ml dH2O /day) can be a highly potential therapeutic agent on the diabetes induced 
alterations. 
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INTRODUCTION 
Diabetic neuropathies (DNPs) are a group of nerve 
disorders caused by diabetes mellitus (DM). Patients 
with DNPs can experience numbness, weakness and 
sometimes pain in the extremities due to the damage in 
nerves throughout the body [1]. Patients can develop 
nerve problems at any time during DM. However the 
one having longer DM has greater risk for neuropathtic 
problems. The highest rate of DNPs is seen among 
those who have had the disease for at least 25 years 
[2]. DNPs also seem to be more frequent in patients 
who have had problems in controlling their blood 
glucose levels, in those with high levels of blood fat and 
blood pressure, and in patients over the age of 40. As a 
result, DNPs are the most common cause of non-
traumatic amputations and autonomic failure [3]. In 
their lifetime, patients with DNPs have 15% probability 
of undergoing one or more amputations [4]. 
For the majority of the cases, animal models of 
diabetes are the most extensively chosen for the 
examination of the DM induced secondary 
complications [5-10]. In these models, within a few 
days, hyperglycemia develops which is then followed 
by a reduction in nerve CV and a loss of sensitivity. 
Nearly one month after the onset of DM, a reduction in  
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the size of the myelin sheath is also evidenced by 
histomorphometry in the sciatic nerves [11]. The 
severity of neuropathy in these experimental models, 
like in humans, depends on both the time and the level 
of exposure to high blood glucose levels [11]. Many of 
the research projects dealing with the DM related 
secondary complications ends up with the excessive 
free radical generation phenomenon. Increased 
production and/or attenuated clearance of reactive 
oxygen species (ROS), collectively named as oxidative 
stress, have been postulated as a possible mechanism 
for both defective nerve blood supply and endoneurial 
damage [12-15]. 
NeOL is an evergreen flowering shrub belongs to 
the dogbane family: Apocynaceae. The parts of NeOL 
that contain cardiac glycosides are collectively called 
as nerine and oleandrin [16]. Although NeOL had been 
used as a folklore medicine for the congestive heart 
failure diseases [17, 18]. It has been reported that the 
leaves of NeOL possess hypolipidemic [19], 
hypoglycemic [20, 21] and an anticonvulsant activity in 
some of the central nervous system activities [22]. 
Although the hypolipidemic and hypoglycemic 
potential of NeOL have been screened, there has been 
no report on the possible therapeutic and/or protective 
effect of NeOL on the DNP changes. Therefore current 
study aims to investigate the possible role of NEOL 
distillate (375 µg /0.5 ml dH2O /day) on the DNP. 
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METHODS AND MATERIALS 
Experimental Animals 
All animals were cared for in accordance with the 
National Institutes of Health’s (NIH) Guide for the care 
and use of laboratory animals. These protocols were 
reviewed and approved by the animal use committee 
(Selçuk University Ethics Committee of the Faculty of 
Veterinary Medicine, Konya, Turkey, report no: 
2010/058). To eliminate the sex dependent differences 
on CV measurements, male Sprague-Dawley rats of 
12-14 weeks of age were used for the experiments. 
After birth, the animals were housed as three rats per 
cage at ambient (23±1 oC) temperature and a 12-h 
light/dark cycle. Unless otherwise stated throughout the 
experiments animals were fed with standard rat diet 
and water without restrictions. 
Under light anesthesia (30 mg/kg i.p. sodium 
pentobarbital), sciatic nerves were dissected from the 
back foot of the Spraque Dawley immediately after the 
rats were sacrificed by cervical dislocation and 
exsanguinations. Nerves were then rapidly transferred 
to the recording chamber, which was super fused with 
a fresh modified Locke’s solution (mmol/l): 140 NaCl, 
5.6 KCl, 2.2 CaCl2, 1.2 MgCl2, 10 glucose and 10 Tris-
(hydroxymethyl- aminomethane), pH 7.3 at a constant 
rate of 3 ml/min (which was controlled online by 
Biopack MP35 data acquisition system).  
Obtaining a Lyophilized NeOL 
NEOL plant was collected among new shoots in 
March-September period from Mediterranean region of 
Turkey, identified and authenticated at the department 
of biology. After washing the collected plant, fresh 
shoots were chopped, and distilled water (100 g NEOL 
plant/1000 ml water) were added. NeOL distillate was 
obtained by heating the mixture in heat resistant 
container. Then, NeOL distillate was lyophilized in 
small glass bottle (20 ml) by using lyophilizator (Patent 
No: WO/2010/082906 Use of Nerium Oleander for 
Diseases Manifested with Type II Diabetes, Obesity, 
High Cholesterol and Triglyceride). Lyophilized NeOL 
distillate was dissolved at the concentration of 750 
µg/ml in distilled water. 
Induction of Diabetes and Experimental Groups  
Animals were randomly divided into three groups 
each of which having 10 rats. For the induction of type 
2 diabetes (for two groups), streptozotocin (single STZ 
35 mg/kg, which was dissolved in citrate buffer (pH 4.5) 
was administered intraperitoneally together with the 
high fat diet for four weeks. One week after STZ 
injection, rats with ≥300 mg/dl non-fasting blood 
glucose level were considered to be type 2 diabetic. 
The treatment and the diet content of experimental 
animal groups were as follows; Control group animals 
(Con): Healthy control rats fed with normal pellet diet 
and did not have the NeOL distillate; DM group animals 
(DM): Type 2 DM rats fed with high fat diet and did not 
have NeOL distillate; NeOL treated DM animals 
(DM+NeOL): Type 2 DM rats fed with high fat diet. The 
NeOL distillate at a dose of 375 µg /0.5 ml of distilled 
water was administrated by gavage once in a day from 
seventh day of diabetes induction to the end of the 
experiment. 
CV Recordings 
Following the integration of the isolated nerves to 
recording chamber, stimulations were applied from the 
proximal end of the nerve trunk while the recordings 
were done from the distal end of the nerve by means of 
suction electrode. The rectangular in shape stimulus 
have a 100-ms duration having supramaximal 
amplitude with a frequency of 1 Hz in nature. CV 
recordings were performed through a suction electrode 
from the tibia branch of the nerve trunk. Pre-amplified 
signals were digitized at 100 kHz sampling rate with 
Biopack MP35 data acquisition system and stored in a 
hard disk for further analysis. 
Statistics 
The measured parameters were compared with 
paired t-test, p < 0.05 values were taken as significant. 
Data are presented as mean ± s.e.m throughout the 
text. 
RESULTS 
General and Biochemical Characteristics of the 
Experimental Animals 
Mean body weights, the blood glucose levels of the 
experimental groups were summarized in Table 1. All 
the experimental group animals gained weight during 
the experimental period. Mean blood glucose levels of 
both non-treated (DM) and NeOL treated DM groups 
were found to be significantly higher than the control 
group animals at the end of the experiments. However, 
NeOL treatment decreased the BG values compared to 
DM group  
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Effect of NeOL Treatment on Compound Action 
Potential Parameters 
Sciatic nerve CAPs were recorded by suction 
electrode, and parameters for general CAP 
appearance are shown in Figures (1, 2, 3 and 4). 
Figure 1 shows the representative original traces that 
were obtained from the experimental group of animals. 
In parallel to previous findings DM results in an 
increase in both the time required to reach the MD and 
the repolarization phases of the CAP recordings. 
Treatment of the NeOL for four weeks on the other 
hand results in a restoration to certain extend but this 
restoration was still found to be longer than the aged 
matched control group animal values (Figure 1).  
 
Figure 1: Representative sample sciatic nerve compound 
action potential traces from Control (Con), Type 2 diabetic 
(DM) and nerium oleander treated diabetic (DM + NeOL) 
animals were given. 
The excitability parameters, summarized in Figure 
2, were significantly influenced by the period of 
diabetes mellitus. In Figure 2, both rheobase (A) and 
chronaxie (B) values were found to be increased at the 
end of the DM period. Four weeks of NeOL treatment 
ends up with a complete normalization to age-matched 
control group animals (Figures 2A, B). 
 
Figure 2: Mean measured rheobase (A) and chronaxie (B) 
values of experimental groups of animals. For details and 
number of animals used, see Materials and methods. Values 
are given as mean ± sem. CON, control; DM, Type 2 diabetic 
group; DM + NeOL, Nerium oleander treated diabetic group. 
*P < 0.05 vs. control; #P < 0.05 vs. diabetic group.  
Table 1: General Characteristic of the Experimental Animals 
 Body Weight (g) 
Blood Glucose 
(mg/dL) 
 Start End Start End 
CON 
(N=10) 231.2±5.8 353.8±7.9
* 99.3±3.6 100.1±4.3 
DM 
(N=10) 229.3±5.6 331.0±6.7
* 443.0±35.3α 435.0±23.8α 
DM + NeOL 
(N=10) 232.8±7.2 346.8±9.5
* 497.5±32.4α 333.6±26.5α, # 
In the table Control (Con), type 2 diabetic (DM), oral nerium oleander supplemented type 2 diabetic (DM + NeOL) group of animal values. Body 
weights and blood glucose represented as BW and BG respectively. * represents the degree of significance (P<0.05) compared to mean start 
values. α represents the degree of significance (P<0.05) compared to control while # represents the degree of significance (P<0.05) compared to 
DM group animals. Values are presented as the mean ± sem. 
Effect of Distillated Nerium Oleander Extract on Diabetic Neuropathy Journal of Advanced Neuroscience Research, 2015, Vol. 2, No. 2    19 
As expected, increased TP (time required to reach 
the MD) nature resulted in decreased maximum 
depolarization (MD) values of type 2 DM animal values. 
NeOL treatment to DM animals resulted in a nearly 
complete restoration (Figure 3A). Mean area 
measurements, as a measure for the actively 
contributing nerve fibers, were found to be abolished in 
DM group and treatment here again results in a 
restoration for these parameters (Figure 3B). 
 
Figure 3: Mean measured maximum depolarization (MD) (A) 
and area under the CAP traces (Area) (B) values of 
experimental groups of animals. Values are given as mean ± 
sem. CON, control; DM, Type 2 diabetic group; DM + NeOL, 
Nerium oleander treated diabetic group. *P < 0.05 vs. control; 
#P < 0.05 vs. diabetic group. 
Two-conduction velocity results were based on the 
two latency measurements shown in Figures 4A, B. 
Latencies from stimulus artifact to start of action 
potential were considered the fastest conduction 
velocity (Figure 4A), while latencies to peak of CAP 
attributed to intermediate conduction velocity (Figure 
4B). DM disturbed not only the intermediate conduction 
velocity (due to structural difference, it is the first to be 
affected), but also the fastest conduction velocity. DM-
induced reduction in conduction velocity on the other 
hand was normalized by 4-weeks of NeOL treatment 
(Figures 4A, B). 
 
Figure 4: Results of two latency measurements on the 
experimental group of animals. Conduction velocities of A: 
the fastest group of nerve fibers (CVAP) B: the intermediately 
conducting group (CVMD). Values are given as mean ± SEM. 
CON, control; DM, Type 2 diabetic group; DM + NeOL, 
Nerium oleander treated diabetic group. *P < 0.05 vs. control; 
#P < 0.05 vs. diabetic group. 
DISCUSSIONS 
DNP, type independently, is one of the leading 
secondary complications seen in diabetes. Indeed, it 
increases the incidence of the DM patient’s mortality 
and morbidity seen in longer periods of exposure to 
diabetes. Experimental models of diabetes are the 
most preferred method for studying diabetes induced 
secondary complications since they produce similar 
complications seen in humans within a shorter period 
of time.  
In wide-ranging terms, oxidative stress can be 
described as an imbalance between the generation and 
removal of the reactive oxygen species. Although 
reactive species were originally considered to be 
entirely detrimental to cells, it is now recognized that 
the regulation of reduction-oxidation states of the 
molecules are the key points in modulation of the 
critical cellular functions [23]. This is particularly the 
case for neurons, astrocytes, and microglia in regard to 
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mitogen-activated protein kinase cascade activation, 
ion transport, calcium homeostasis, and apoptosis 
program activation. Furthermore, the role of oxidative 
stress is significant in neurological manifestation of 
mitochondrial diseases, as well as the new concept of 
“mitochondrial respiratory chain diseases” [24]. 
Antioxidant therapy in experimental DNP blocks the 
observed decrease in nerve growth factor expression 
and restores nerve function [5, 25]. In addition to many 
of the parameters, antioxidant therapy restores nerve 
conduction velocities in experimentally induced 
diabetes mellitus [13, 14, 26-29]. Therefore, to 
preserve the reduction-oxidation environment of 
cellular and mitochondrial function, it is helpful to 
increase antioxidant defenses with fruits and 
vegetables rich in antioxidants. Studies have shown 
that NeOL is a potential antioxidant that involve in the 
defense against reactive oxygen species toxicity [30]. It 
has also been shown that the antioxidant nature of 
NeOL includes free radical scavenging and reducing 
power in a concentration dependent manner [31, 32].  
Current study for the first time showed that NeOL 
distilate supplementations (375 µg/0.5 ml dH2O/day) 
can prevent DM induced CV dysfunctions. This 
restorative effect covers the excitability (rheobase and 
chronaxie), contributes to conduction velocities 
(intermediately and fastest nerve fibers). Although we 
believe that the positive effect seen in here is most 
probably due to NeOL’s antioxidants nature and its 
anti-hyperglycemic effect, still it is obvious that 
molecular mechanism of the mode of action needs 
further investigations.  
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